Medical News
Addiction
Allergies
Alternative Medicine
Asthma
Cancer
Cardiology
Chiropractic
Dental
Dermatology
Diabetes
Emergency
Family Medicine
General
Geriatrics
Hospitals
Infectious Diseases
Internal Medicine
Managed Care / HMO
Medical Products
Mental Health
Neurology
Nursing
Nutrition
OB / GYN
Pediatrics
Pharmaceuticals
Physical Therapy
Plastic Surgery
Psychology
Radiology / Imaging
Research
Sports Medicine
Surgery
Vision

New Reaction Block for Organic Synthesis and Process Screening

Press Release Attachment
Press Release Attachment

METTLER TOLEDO recently launched the MiniBlock® XT-S, an affordable reaction block for Organic Synthesis and Process Screening.

Columbia, MD (PRWEB) May 29, 2008 -- METTLER TOLEDO recently launched the MiniBlock® XT-S, an affordable reaction block for Organic Synthesis and Process Screening.

MiniBlock® XT-S enables the chemist to save time and valuable starting materials by utilizing small scale parallel synthesis to answer important research questions. The XT-S has removable racks which easily change the scale and array providing flexibility for your project needs. The XT-S is part of the MiniBlock® product family, which is the only compact parallel synthesizer that enables solid phase synthesis, solution phase synthesis, and purification to be carried out on the same platform. Applications for MiniBlock® include parallel solid phase synthesis, parallel solution phase synthesis, process screening and process route scouting.

###

Simillar Articles

The First Automated Synthesis Tool That Requires No Training: EasyMax™ 102
Mettler Toledo introduces EasyMax™ 102, the new generation automated lab reactor system for the synthesis lab and the synthetic organic chemist. EasyMax™ 102 replaces the traditional...
AsisChem Expands Chemical Catalog
Cambridge-based AsisChem continues to grow its catalog and expand its distribution partnerships.
Genome Synthesis and Design Futures: Implications for the U.S. Economy
Bio-era releases new report analyzing economic implications of rapid advances in gene sequencing and synthesis technologies -- big changes coming for energy, chemicals, and vaccine production.
New England Peptide Names Director of Chemical Development
New England Peptide, LLC (NEP), has named Robert P. Hammer, Ph.D., director of chemical development.
SkinEnergizer.com Announces Dermory ST® Breast Firming Cream
Dermory ST®, an advanced breast firming cream from SkinEnergizer.com, is a concentrated biopeptide formula that provides breast firming with Bio-Bustyl®, Hyaluronic Acid and soothing Aloe...
Home Terms of Use Privacy Policy Contact Us